H3K27ac HiChIPs from EBV-infected LCLs
Corresponding Organization : Beth Israel Deaconess Medical Center
Other organizations : Brigham and Women's Hospital, Harvard University, Moffitt Cancer Center, Sun Yat-sen University, Sun Yat-sen University Cancer Center, Cincinnati Children's Hospital Medical Center
Variable analysis
- EBNA3A expression
- H3K27ac HiChIP
- Cell line: LCLs (Lymphoblastoid Cell Lines)
- Antibody: Anti-H3K27ac antibody (Abcam)
- Enzyme: MboI restriction enzyme (New England Biolabs)
- Sequencing platform: Illumina NextSeq 500
- Average sequencing depth: ~20 million reads per sample
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!